For archived material
older than 2012,
Publication: Information Management
Known as the General Data Protection Regulation or GDPR, the EU describes the new requirements as “the most important change in data privacy regulation in 20 years.” Intended to replace the current European Data Protection Directive and standardize the laws governing data privacy across the EU’s member countries, it is meant to reshape the way organizations across the region deal with data privacy.
Publication: Clinical Leader
A survey of top corporate data protection challenges has found only 6 percent of companies are prepared to be compliant with the EU’s General Data Protection Regulation (GDPR), which goes into effect on May 25, 2018. The Compliance, Governance, and Oversight Council (CGOC) released the results of the survey, which gathered the results from 132 compliance officers from organizations around the world. Those organizations were across multiple industries.
GDPR is a growing concern for companies in the life sciences industry. A session at DIA’s annual meeting in Chicago in June 2017 brought the issue to the attention of many pharma executives in the audience. Violations of the regulation can result in a penalty of €20 million or 4 percent of worldwide revenue.
Not a member? Join the community
Already a member? Sign in
Become a CGOC Member and have access to resources, white papers, surveys, proceedings, and practice tools such as the Information Economic Process Assessment Kit. CGOC Members receive first priority to regional CGOC executive meetings around the world.
Asterisks (*) indicate fields required for registration